{"id": "1337055706848047106", "creation": 1607613896.0, "user_id": "1278721792765378561", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "Zydus Cadila Pharmaceuticals announces the company has received an approval from the Drugs Controller General of India to begin phase-III clinical trials with its biological therapy Pegylated Interferon alpha-2b (PegiHep) in #COVID19 patients.\n\n#vaccine https://t.co/Ez1lI9XgR0", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}